✦ LIBER ✦

Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study

✍ Scribed by Ofer Merimsky; Isaac Meller; Gidon Flusser; Yehuda Kollender; Josephine Issakov; Miriam Weil-Ben-Arush; Eyal Fenig; Gad Neuman; Dov Sapir; Shmuel Ariad; Moshe Inbar; for the Israeli Soft Tissue and Bone Sarcoma Treatment Groups

Publisher: Springer
Year: 2000
Tongue: English
Weight: 77 KB
Volume: 45
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine at fixed dose-rate in patien

Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study

✍ Virginia Ferraresi; Mariangela Ciccarese; Maria Cecilia Cercato; Carmen Nuzzo; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 304 KB

Phase II study of weekly docetaxel and f

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma

✍ Eun Mi Lee; Sun Young Rha; Jeeyun Lee; Kyong Hwa Park; Jin-Hee Ahn 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

Phase II study of a protracted irinoteca

Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma

✍ Gianni Bisogno; Riccardo Riccardi; Antonio Ruggiero; Giampaolo Arcamone; Arcange 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## BACKGROUND Irinotecan (CPT‐11) is a novel antineoplastic agent that takes effect by inhibiting topoisomerase I. The Italian Soft Tissue Sarcoma (STS) Committee performed a multiinstitutional Phase II study to evaluate its effect on STS. ## METHODS Over a 2‐year period between 2002

Phase II study of intravenous TZT-1027 i

Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy

✍ Shreyaskumar Patel; Mary Louise Keohan; M. Wasif Saif; Daniel Rushing; Luis Baez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

Ifosfamide/liposomal daunorubicin is a w

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma : Results of a Phase II study

✍ Jan M. Siehl; Eckhard Thiel; Alexander Schmittel; Gero Hütter; Peter M. Deckert; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Prolonged low dose IL-2 and thalidomide

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study

✍ J. M. Kerst; A. Bex; H. Mallo; L. Dewit; J. B. A. G. Haanen; W. Boogerd; H. J. T 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 293 KB